255 related articles for article (PubMed ID: 28771465)
21. EBV persistence without its EBNA3A and 3C oncogenes in vivo.
Murer A; McHugh D; Caduff N; Kalchschmidt J; Barros M; Zbinden A; Capaul R; Niedobitek G; Allday M; Chijioke O; Münz C
PLoS Pathog; 2018 Apr; 14(4):e1007039. PubMed ID: 29709016
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9.
Harth-Hertle ML; Scholz BA; Erhard F; Glaser LV; Dölken L; Zimmer R; Kempkes B
PLoS Pathog; 2013 Sep; 9(9):e1003638. PubMed ID: 24068939
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression.
Maruo S; Zhao B; Johannsen E; Kieff E; Zou J; Takada K
Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1919-24. PubMed ID: 21245331
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of
Gillman ACT; Parker G; Allday MJ; Bazot Q
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135119
[TBL] [Abstract][Full Text] [Related]
25. The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency.
Styles CT; Paschos K; White RE; Farrell PJ
Pathogens; 2018 Mar; 7(1):. PubMed ID: 29562595
[TBL] [Abstract][Full Text] [Related]
26. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.
Anderton E; Yee J; Smith P; Crook T; White RE; Allday MJ
Oncogene; 2008 Jan; 27(4):421-33. PubMed ID: 17653091
[TBL] [Abstract][Full Text] [Related]
27. A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.
Knight JS; Sharma N; Kalman DE; Robertson ES
J Virol; 2004 Dec; 78(23):12857-67. PubMed ID: 15542638
[TBL] [Abstract][Full Text] [Related]
28. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
29. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa).
Robertson ES; Lin J; Kieff E
J Virol; 1996 May; 70(5):3068-74. PubMed ID: 8627785
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells.
Wang L; Laing J; Yan B; Zhou H; Ke L; Wang C; Narita Y; Zhang Z; Olson MR; Afzali B; Zhao B; Kazemian M
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999023
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.
Jiang S; Willox B; Zhou H; Holthaus AM; Wang A; Shi TT; Maruo S; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):421-6. PubMed ID: 24344258
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.
Vrzalikova K; Vockerodt M; Leonard S; Bell A; Wei W; Schrader A; Wright KL; Kube D; Rowe M; Woodman CB; Murray PG
Blood; 2011 Jun; 117(22):5907-17. PubMed ID: 21411757
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.
Jha HC; A J MP; Saha A; Banerjee S; Lu J; Robertson ES
J Virol; 2014 Apr; 88(7):3776-88. PubMed ID: 24429368
[TBL] [Abstract][Full Text] [Related]
35. EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.
Saha A; Bamidele A; Murakami M; Robertson ES
J Virol; 2011 Mar; 85(5):2079-88. PubMed ID: 21177815
[TBL] [Abstract][Full Text] [Related]
36. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
37. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
[TBL] [Abstract][Full Text] [Related]
38. The Epstein-Barr Virus Regulome in Lymphoblastoid Cells.
Jiang S; Zhou H; Liang J; Gerdt C; Wang C; Ke L; Schmidt SCS; Narita Y; Ma Y; Wang S; Colson T; Gewurz B; Li G; Kieff E; Zhao B
Cell Host Microbe; 2017 Oct; 22(4):561-573.e4. PubMed ID: 29024646
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.
Bourillot PY; Waltzer L; Sergeant A; Manet E
J Gen Virol; 1998 Feb; 79 ( Pt 2)():363-70. PubMed ID: 9472621
[TBL] [Abstract][Full Text] [Related]
40. B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
Romero-Masters JC; Huebner SM; Ohashi M; Bristol JA; Benner BE; Barlow EA; Turk GL; Nelson SE; Baiu DC; Van Sciver N; Ranheim EA; Gumperz J; Sherer NM; Farrell PJ; Johannsen EC; Kenney SC
PLoS Pathog; 2020 Feb; 16(2):e1008365. PubMed ID: 32059024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]